Clinical Trials Directory

Trials / Terminated

TerminatedNCT05545735

The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days

Duration of Antibiotic Therapy for Early (DATE) Ventilator-Associated Pneumonia (VAP) Trial: A Surgical Infection Society Multicenter Randomized Clinical Trial of 4 vs. 7 Days of Definitive Antibiotic Therapy for Early VAP

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
27 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if the amount of antibiotics given for ventilator-associated pneumonia (VAP) can be decreased in order to reduce the risk of adverse effects associated with antibiotics, while at the same time ensuring the participant's safety.

Conditions

Interventions

TypeNameDescription
DRUGStandard of Care Antibiotic TherapyAntibiotics will be administered as per the standard of care orally via tablet

Timeline

Start date
2023-05-08
Primary completion
2025-02-27
Completion
2025-02-27
First posted
2022-09-19
Last updated
2026-01-16
Results posted
2026-01-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05545735. Inclusion in this directory is not an endorsement.